Werewolf Therapeutics (HOWL) Earnings Date & Reports

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HOWL is expected to report earnings to -28 cents per share on August 06

Werewolf Therapeutics HOWL Stock Earnings Reports

Q2'26

Est.

$-0.28

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.14

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.07

The last earnings report on May 07 showed earnings per share of -28 cents, missing the estimate of -27 cents. With 338.75K shares outstanding, the current market capitalization sits at 17.99M.

View a ticker or compare two or three

Compare

HOWL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HOWL